A clinical study showed daily supplementation with chromium picolinate improved cognitive function in older adults experiencing early memory decline. The results suggest that improving glucose metabolism with chromium picolinate supplementation may enhance cognition.
A clinical study showed Diachrome significantly improved glycemic control in patients with poorly controlled blood sugar levels, reducing A1C by 0.54% and fasting glucose by 9.8 mg/dL. The greatest improvement was seen in those with the poorest glycemic control, who experienced an additional absolute A1C decrease of 1.76%.
A review published in Diabetes Technology & Therapeutics confirms chromium picolinate's benefits in improving glycemic control and normalizing lipid levels. Higher doses of chromium picolinate are required for people with type 2 diabetes, and its greater bioavailability may explain its superior effects.
A recent study published in Diabetes Technology and Therapeutics demonstrated that Diachrome safely improves blood glucose levels and cholesterol metabolism in people with type 2 diabetes. The 30-day study showed a significantly greater reduction in glucose levels, suggesting potential benefits for improved blood sugar control.